atag-4531

Degrader of MTH1 fusion proteins for use within the aTAG system. Comprises a ligand selective for MTH1, a linker and the cereblon-binding ligand Thalidomide . Induces highly potent and selective degradation of fusion proteins after a 4 h incubation (DC50 = 0.34 nM; Dmax = 93.14%). Cell-permeable. Suitable for in vitro and in vivo applications. Mouse DMPK properties are provided in the supplementary file (see below). (MTH1 can be expressed as a fusion with a target protein of interest using genome engineering techniques via CRISPR-mediated locus-specific knock-in - see protocol for more information.) 0

Thalidomide-O-Triazole-C4-amino is an E3 ubiquitin ligase ligand-linker conjugate (E3 Ligase Ligand-linker conjugate) designed for the synthesis of aTAG 4531.

MTH1 degrader-1 is an inhibitor of MTH1 aTAG and serves as a ligand for target proteins in PROTAC applications. It is used in the synthesis of PROTAC aTAG 4531.